MMP2 and congestive heart failure: Between 12 and 15 months there was a much more rapid decline in functional parameters in the transgenic mice, with large increases in LVESV, LVEDV and LV mass, associated with clinical findings of congestive heart failure (Figure S2 depicts representative 14 month old wild type and NTT-MMP-2 transgenic mice).